Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5151
Source ID: NCT00754403
Associated Drug: Pioglitazone And Metformin
Title: Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: Pioglitazone and metformin|DRUG: Metformin
Outcome Measures: Primary: Change from randomization in Glycosylated Hemoglobin, Final Visit | Secondary: Change from randomization in Fasting Plasma Glucose, Final Visit|Change from randomization in Insulin, Final Visit|Change from randomization in Pro-Insulin, Final Visit|Change from randomization in Homeostasis Model Assessment, Final Visit|Change from randomization in Triglycerides, Final Visit|Change from randomization in Total Cholesterol, Final Visit|Change from randomization in Low-Density Lipoprotein Cholesterol, Final Visit|Change from randomization in high-density Lipoprotein Cholesterol, Final Visit|Change from randomization in Lipid Fractionation, Final Visit|Change from randomization in High Sensitivity C-Reactive Protein, Final Visit|Change from randomization in Creatine Phosphokinase, Final Visit
Sponsor/Collaborators: Sponsor: Takeda
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 312
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2005-07
Completion Date: 2006-10
Results First Posted:
Last Update Posted: 2010-07-05
Locations:
URL: https://clinicaltrials.gov/show/NCT00754403

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D336 Pioglitazone small molecule DB01132 Details
D089 Metformin small molecule DB00331 Details